Clinical implication of the presence of hepatitis C virus antibodies after kidney transplantation in Japan.
Tomikawa
S
S
Institute of Medical Science, University of Tokyo, Japan.
Ito
S
S
Kikuchi
K
K
Ando
Y
Y
Ichikawa
N
N
Meigata
K
K
Nomura
Y
Y
Watanabe
K
K
Degawa
H
H
Beck
Y
Y
Nagao
T
T
Uchida
H
H
D001803:Blood Transfusion; D002102:Cadaver; D005260:Female; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000453:epidemiology* / Q000635:transmission; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D011183:Postoperative Complications; D006435:Renal Dialysis; D012189:Retrospective Studies; D014019:Tissue Donors
D018937:Hepatitis C Antibodies; D007166:Immunosuppressive Agents